title: Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia.
abstract: Our case report demonstrates the use of phase contrast magnetic resonance imaging (MRI) in monitoring the functional status of liver vasculature in a patient with hereditary hemorrhagic telangiectasia (HHT) who was treated with bevacizumab. Our report provides additional information that can be further utilized in clinical settings and research.
authors: Radiology, Austin Health Melbourne, Victoria, Australia.
authors: Numan
authors: N
authors: Kutaiba
authors: Liver Transplant Unit, Austin Hospital Melbourne, Victoria, Australia.
authors: Paul J
authors: PJ
authors: Gow
authors: Liver Transplant Unit, Austin Hospital Melbourne, Victoria, Australia.
authors: Janine
authors: J
authors: French
authors: Radiology, Austin Health Melbourne, Victoria, Australia.
authors: Ruth P
authors: RP
authors: Lim
keywords: Angiogenesis inhibitors; blood flow velocity; hepatic artery; hereditary hemorrhagic telangiectasia; magnetic resonance imaging